|
Market Cap | 7.70B | EPS (ttm) | -2.73 |
P/E | - | EPS this Y | 2.10% |
Forward P/E | - | EPS next Y | -10.64% |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 13.61 | EPS Q/Q | -9.10% |
Dividend | - | Sales Q/Q | - |
Insider Own | 52.09% | Inst Own | 44.94% |
Insider Trans | -0.40% | Inst Trans | 4.98% |
Short Float | 7.56% | Earnings | Nov 01/b |
Analyst Recom | 2.67 | Target Price | 45.00 |
Avg Volume | 1.32M | 52W Range | 19.59 - 43.59 |
|
|
May-13-24 09:07PM
|
CEREVEL THERAPEUTICS HOLDINGS, INC. (CERE) ACQUISITION ALERT: Is AbbVie Inc.'s Offer of $45 per CERE Share a Fair Deal? Bleichmar Fonti & Auld LLP is Currently Investigating the Acquisition
(Newsfile) |
May-09-24 12:53AM
|
CERE Stock Earnings: Cerevel Therapeutics Hldg Misses EPS for Q2 2024
(InvestorPlace) |
Apr-18-24 12:18PM
|
Heard on the Street: AbbVies Bet on a Neuroscience Drug Maker Just Got Better
(The Wall Street Journal) |
06:30AM
|
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson's Disease
(GlobeNewswire) |
Mar-17-24 08:50AM
|
30 Biggest Biotechnology Companies in the World
(Insider Monkey) |
Jan-29-24 02:23PM
|
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates MGRC, SNCE, VINE, CERE
(PR Newswire) |
Jan-24-24 09:45AM
|
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates WAVD, CERE, TGAN
(GlobeNewswire) |
08:30AM
|
Kuehn Law Encourages MDC, WAVD, NS and CERE Investors to Contact Law Firm
(PR Newswire) |
Jan-23-24 02:45PM
|
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates CSTR, SIX, CERE, EGLE
(PR Newswire) |
Jan-02-24 06:10PM
|
Kuehn Law Encourages CERE, HA, IMGN, and WAVD Investors to Contact Law Firm
(PR Newswire) |
|
Cerevel Therapeutics Holdings, Inc. engages in the discovery and development of new therapies for neuroscience diseases. The firm's portfolio focuses on diseases such as schizophrenia, epilepsy, and Parkinson's disease. Its product candidates include CVL-231, Darigabat, Tavapadon, CVL-871, and CVL-936. The company was founded in 2018 and is headquartered in Cambridge, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
COLES N ANTHONY | Director | May 10 '24 | Option Exercise | 3.50 | 50,000 | 175,000 | 65,638 | May 14 05:16 PM | COLES N ANTHONY | Director | May 10 '24 | Sale | 42.10 | 50,000 | 2,105,125 | 15,638 | May 14 05:16 PM | COLES N ANTHONY | Director | Apr 01 '24 | Option Exercise | 3.50 | 50,000 | 175,000 | 65,638 | Apr 03 04:15 PM | COLES N ANTHONY | Director | Apr 01 '24 | Sale | 42.33 | 50,000 | 2,116,640 | 15,638 | Apr 03 04:15 PM | COLES N ANTHONY | Director | Mar 04 '24 | Option Exercise | 3.50 | 50,000 | 175,000 | 65,638 | Mar 06 04:15 PM |
|
|
|
|
Market Cap | 8.49B | EPS (ttm) | 0.63 |
P/E | 99.56 | EPS this Y | 21.41% |
Forward P/E | 18.99 | EPS next Y | 17.47% |
PEG | 6.03 | EPS past 5Y | -7.04% |
P/S | 4.47 | EPS next 5Y | 16.50% |
P/B | 2.16 | EPS Q/Q | -110.94% |
Dividend | - | Sales Q/Q | 119.26% |
Insider Own | 17.29% | Inst Own | 82.14% |
Insider Trans | -0.43% | Inst Trans | 1.57% |
Short Float | 8.05% | Earnings | May 07/a |
Analyst Recom | 2.29 | Target Price | 66.96 |
Avg Volume | 1.18M | 52W Range | 43.38 - 65.74 |
|
|
May-13-24 07:07AM
|
Morgan Stanley Raises Price Target on Globus Medical to $67 From $57, Keeps Equalweight Rating
(MT Newswires) |
May-10-24 04:52PM
|
Globus Medical Insider Sold Shares Worth $1,300,000, According to a Recent SEC Filing
(MT Newswires) |
May-09-24 11:57AM
|
Barclays Adjusts Price Target on Globus Medical to $85 From $83, Maintains Overweight Rating
(MT Newswires) |
09:15AM
|
Globus Medical, Inc. (GMED) Hit a 52 Week High, Can the Run Continue?
(Zacks) |
07:58AM
|
Surgical robots are gift that will keep on giving, ortho firms say
(MedTech Dive) |
May-08-24 12:39PM
|
Globus Medical Shares Rise After Stifel, Truist Adjust Price Targets Upwards
(MT Newswires) +20.19% |
11:32AM
|
Globus Medical, Inc. (NYSE:GMED) Q1 2024 Earnings Call Transcript
(Insider Monkey) |
11:00AM
|
Stifel Adjusts Price Target on Globus Medical to $70 From $64, Maintains Buy Rating
(MT Newswires) |
10:33AM
|
Globus Medical Up 23% As Q1 Results Beat Street; Raises FY Outlook
(RTT News) |
09:40AM
|
Why Globus Medical (GMED) is a Top Value Stock for the Long-Term
(Zacks) |
|
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Lemaitre Dan | Director | May 10 '24 | Option Exercise | 46.87 | 52,500 | 2,460,850 | 63,300 | May 14 05:16 PM | Lemaitre Dan | Director | May 10 '24 | Sale | 64.61 | 63,300 | 4,090,022 | 0 | May 14 05:16 PM | Davidar David D | Director | May 08 '24 | Sale | 65.00 | 20,000 | 1,300,000 | 566,275 | May 10 04:48 PM | Norwalk Leslie V | Director | Mar 15 '24 | Sale | 51.99 | 10,590 | 550,574 | 17,419 | Mar 19 07:40 PM | Huller Kelly | SVP, GC, Corporate Secretary | Mar 01 '24 | Option Exercise | 24.90 | 7,500 | 186,750 | 7,500 | Mar 05 05:07 PM |
|
|
|
|
Market Cap | 4.92B | EPS (ttm) | 1.09 |
P/E | 27.85 | EPS this Y | 12.42% |
Forward P/E | 16.53 | EPS next Y | 13.93% |
PEG | 1.89 | EPS past 5Y | 27.64% |
P/S | 2.95 | EPS next 5Y | 14.75% |
P/B | 6.12 | EPS Q/Q | -3.34% |
Dividend | - | Sales Q/Q | 8.95% |
Insider Own | 5.12% | Inst Own | 96.66% |
Insider Trans | -1.07% | Inst Trans | -0.30% |
Short Float | 3.70% | Earnings | May 02/b |
Analyst Recom | 1.55 | Target Price | 36.61 |
Avg Volume | 1.09M | 52W Range | 25.17 - 33.40 |
|
|
|
ExlService Holdings, Inc. is an operations management and analytics company, which engages in providing business process management. It operates through the following segments: Insurance, Healthcare, Travel, Transportation, and Logistics, Finance and Accounting, Analytic, and All Other. The Insurance segment serves property and casualty insurance, life insurance, disability insurance, annuity, and retirement services companies. The Healthcare segment offers services related to care management or population health, payment integrity, revenue optimization, and customer engagement. The Travel, Transportation, and Logistics segment includes business processes in corporate and leisure travel such as reservations, customer service, fulfillment, and finance and accounting. The Finance and Accounting segment is comprised of procure-to-pay, order-to-cash, hire-to-retire, record-to-report, regulatory reporting, financial planning and analysis, audit and assurance, treasury, and tax processes. The Analytics segment consists of driving improved business outcomes for customers by generating data-driven insights. The All-Other segment is involved in banking, financial, utilities, and consulting services. The company was founded by Vikram Talwar and Rohit Kapoor in April 1999 and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Kapoor Rohit | Chairman & CEO | May 13 '24 | Sale | 30.47 | 30,000 | 914,100 | 1,586,435 | May 14 05:15 PM | Kapoor Rohit | Chairman & CEO | May 10 '24 | Sale | 30.61 | 15,000 | 459,150 | 1,616,435 | May 14 05:15 PM | Nicolelli Maurizio | Executive Vice President & CFO | May 08 '24 | Sale | 30.66 | 12,000 | 367,920 | 138,985 | May 10 05:02 PM | AYYAPPAN AJAY | EVP & Gen Counsel/Corp. Sec'y. | Mar 12 '24 | Sale | 31.59 | 9,259 | 292,492 | 50,693 | Mar 14 05:04 PM | Bhalla Vikas | EVP & Head of Outsourcing | Mar 06 '24 | Sale | 31.51 | 23,760 | 748,678 | 127,046 | Mar 08 05:09 PM |
|
|
| |
|
Market Cap | 54.78B | EPS (ttm) | 4.94 |
P/E | 50.78 | EPS this Y | 15.72% |
Forward P/E | 22.07 | EPS next Y | 12.06% |
PEG | 4.79 | EPS past 5Y | 5.38% |
P/S | 5.23 | EPS next 5Y | 10.60% |
P/B | 4.85 | EPS Q/Q | 22.24% |
Dividend | 0.96% | Sales Q/Q | 20.41% |
Insider Own | 1.24% | Inst Own | 86.56% |
Insider Trans | -3.79% | Inst Trans | 1.87% |
Short Float | 0.83% | Earnings | Apr 25/a |
Analyst Recom | 2.05 | Target Price | 263.47 |
Avg Volume | 806.46K | 52W Range | 198.52 - 256.10 |
|
|
|
Arthur J. Gallagher & Co. engages in the provision of insurance brokerage, reinsurance brokerage, consulting, and third-party claims settlement and administration services. It operates through the following business segments: Brokerage, Risk Management, and Corporate. The Brokerage segment consists of retail and wholesale insurance brokerage operations. The Risk Management segment provides contract claim settlement and administration services. The Corporate segment manages clean energy and other investments. The company was founded by Arthur J. Gallagher in 1927 and is headquartered in Rolling Meadows, IL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
HOWELL DOUGLAS K | VP & Chief Financial Officer | May 10 '24 | Sale | 248.41 | 16,000 | 3,974,558 | 80,952 | May 14 05:14 PM | BARRAT SHERRY S | Director | May 09 '24 | Option Exercise | 0.00 | 920 | 0 | 20,758 | May 13 06:43 PM | Clarke Teresa Hillary | Director | May 09 '24 | Option Exercise | 0.00 | 920 | 0 | 2,880 | May 13 06:56 PM | Coldman David John | Director | May 09 '24 | Option Exercise | 0.00 | 920 | 0 | 13,694 | May 13 06:58 PM | JOHNSON DAVID S | Director | May 09 '24 | Option Exercise | 0.00 | 920 | 0 | 45,958 | May 13 07:02 PM |
|
|
|
|
Market Cap | 1.80B | EPS (ttm) | -0.43 |
P/E | - | EPS this Y | 32.61% |
Forward P/E | - | EPS next Y | 27.42% |
PEG | - | EPS past 5Y | - |
P/S | 8.65 | EPS next 5Y | 31.20% |
P/B | 1.67 | EPS Q/Q | 22.83% |
Dividend | - | Sales Q/Q | -52.98% |
Insider Own | 32.59% | Inst Own | 55.85% |
Insider Trans | -0.60% | Inst Trans | 4.32% |
Short Float | 20.76% | Earnings | May 09/a |
Analyst Recom | 3.43 | Target Price | 1.62 |
Avg Volume | 34.45M | 52W Range | 0.72 - 2.55 |
|
|
|
Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. It operates through the Cell Programming/Foundry, and Biosecurity segments. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
SLOAN HARRY | Director | May 14 '24 | Buy | 0.91 | 297,619 | 271,815 | 718,540 | May 14 05:16 PM | DEKKERS MARIJN E | Director | May 14 '24 | Sale | 0.93 | 1,727,056 | 1,606,162 | 281,217 | May 14 05:13 PM | Coen Steven P. | See remarks | May 02 '24 | Sale | 0.84 | 131,928 | 111,479 | 162,527 | May 06 04:53 PM | Dmytruk Mark E. | See remarks | May 02 '24 | Sale | 0.84 | 47,806 | 40,396 | 925,400 | May 06 04:55 PM | Dmytruk Mark E. | See remarks | Apr 02 '24 | Sale | 1.05 | 51,169 | 53,727 | 865,079 | Apr 04 04:40 PM |
|
|
| |
|
Market Cap | 74.38B | EPS (ttm) | 12.66 |
P/E | 10.22 | EPS this Y | 2.79% |
Forward P/E | 10.48 | EPS next Y | 2.77% |
PEG | 2.32 | EPS past 5Y | 17.16% |
P/S | 3.16 | EPS next 5Y | 4.40% |
P/B | 2.60 | EPS Q/Q | -10.03% |
Dividend | 3.70% | Sales Q/Q | 4.66% |
Insider Own | 0.25% | Inst Own | 92.67% |
Insider Trans | -0.81% | Inst Trans | -0.44% |
Short Float | 1.67% | Earnings | May 02/a |
Analyst Recom | 2.00 | Target Price | 146.83 |
Avg Volume | 3.55M | 52W Range | 104.97 - 139.67 |
|
|
|
EOG Resources, Inc. engages in the exploration, development, production and marketing of crude oil and natural gas. It operates through the United States, Trinidad, and Other International geographical segments. The Other International segment includes China and Canada operations. The company was founded in 1985 and is headquartered in Houston, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Donaldson Michael P | EVP, Gen. Counsel & Corp Sec | May 13 '24 | Sale | 130.29 | 2,685 | 349,839 | 109,040 | May 14 05:13 PM | Leitzell Jeffrey R. | EVP & COO | May 10 '24 | Option Exercise | 96.29 | 6,150 | 592,184 | 51,801 | May 14 12:09 PM | Donaldson Michael P | EVP, Gen. Counsel & Corp Sec | May 10 '24 | Option Exercise | 59.59 | 8,161 | 486,311 | 114,880 | May 14 05:13 PM | Leitzell Jeffrey R. | EVP & COO | May 10 '24 | Sale | 130.07 | 7,802 | 1,014,812 | 39,054 | May 14 12:09 PM | Helms Lloyd W Jr | President | May 09 '24 | Option Exercise | 37.44 | 3,000 | 112,320 | 164,109 | May 13 04:21 PM |
|
|
|
|
Market Cap | 2.91B | EPS (ttm) | -0.23 |
P/E | - | EPS this Y | 42.18% |
Forward P/E | 52.07 | EPS next Y | 381.91% |
PEG | - | EPS past 5Y | - |
P/S | 17.73 | EPS next 5Y | 20.00% |
P/B | 5.45 | EPS Q/Q | -85.56% |
Dividend | - | Sales Q/Q | -2.23% |
Insider Own | 22.38% | Inst Own | 72.00% |
Insider Trans | -14.87% | Inst Trans | 54.35% |
Short Float | 9.14% | Earnings | May 29/a |
Analyst Recom | 1.50 | Target Price | 26.56 |
Avg Volume | 2.01M | 52W Range | 7.96 - 23.90 |
|
|
|
Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam in September 2014 and is headquartered in George Town, Cayman Islands. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Brennan William Joseph | Pres & Chief Executive Officer | Nov 17 '27 | Sale | 17.71 | 15,000 | 265,662 | 3,867,421 | Nov 17 08:52 PM | Brennan William Joseph | Pres & Chief Executive Officer | Oct 24 '24 | Sale | 14.45 | 15,000 | 216,762 | 3,927,421 | Oct 24 05:51 PM | Cheng Chi Fung | Chief Technology Officer | May 10 '24 | Sale | 17.43 | 55,000 | 958,397 | 9,718,602 | May 14 05:13 PM | Lam Yat Tung | Chief Operating Officer | May 10 '24 | Sale | 17.50 | 10,000 | 175,000 | 3,143,738 | May 14 05:12 PM | Brennan William Joseph | Pres & Chief Executive Officer | May 03 '24 | Sale | 17.35 | 15,000 | 260,226 | 2,947,500 | May 03 05:46 PM |
|
|
| |
|
Market Cap | 7.91B | EPS (ttm) | 1.51 |
P/E | 31.79 | EPS this Y | 8.60% |
Forward P/E | 24.82 | EPS next Y | 9.44% |
PEG | 3.18 | EPS past 5Y | 13.25% |
P/S | 3.22 | EPS next 5Y | 10.00% |
P/B | 4.52 | EPS Q/Q | 80.87% |
Dividend | 1.07% | Sales Q/Q | 5.93% |
Insider Own | 2.65% | Inst Own | 91.68% |
Insider Trans | -0.82% | Inst Trans | 0.81% |
Short Float | 3.19% | Earnings | May 08/b |
Analyst Recom | 2.00 | Target Price | 48.83 |
Avg Volume | 1.24M | 52W Range | 35.06 - 49.87 |
|
|
|
The New York Times Co. is a media organization, which engages in creating, collecting, and distributing news and information. It offers news products and other interest-specific products, and related content and services. It offers newspapers, print, and digital products and investments. The firm also manages The New York Times, NYTimes.com, and mobile applications. The company was founded by Henry Jarvis Raymond and George Jones on September 18, 1851, and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
KOPIT LEVIEN MEREDITH A. | PRESIDENT & CEO | May 10 '24 | Sale | 47.72 | 12,548 | 598,841 | 120,072 | May 14 05:05 PM | Brayton Diane | EVP, GENERAL COUNSEL | Feb 22 '24 | Sale | 42.84 | 7,000 | 299,880 | 39,312 | Feb 23 05:25 PM | KOPIT LEVIEN MEREDITH A. | PRESIDENT & CEO | Feb 16 '24 | Sale | 44.11 | 13,543 | 597,382 | 90,759 | Feb 21 05:19 PM | Perpich David S. | Director | Feb 14 '24 | Sale | 44.03 | 3,014 | 132,706 | 20,813 | Feb 15 04:21 PM | Sulzberger Arthur G. | Chairman and Publisher | Aug 11 '23 | Sale | 44.23 | 8,500 | 375,912 | 101,691 | Aug 14 09:17 PM |
|
|
|
|
Market Cap | 7.49B | EPS (ttm) | 8.01 |
P/E | 15.14 | EPS this Y | -4.47% |
Forward P/E | 14.41 | EPS next Y | 9.23% |
PEG | 0.89 | EPS past 5Y | 27.41% |
P/S | 1.06 | EPS next 5Y | 17.00% |
P/B | 2.43 | EPS Q/Q | -1.31% |
Dividend | 0.97% | Sales Q/Q | -10.07% |
Insider Own | 2.32% | Inst Own | 83.01% |
Insider Trans | -4.75% | Inst Trans | -2.01% |
Short Float | 1.30% | Earnings | Apr 30/b |
Analyst Recom | 2.14 | Target Price | 122.57 |
Avg Volume | 302.09K | 52W Range | 77.47 - 128.65 |
|
|
|
UFP Industries, Inc. is a holding company, which engages in the supply of products primarily manufactured from wood, wood and non-wood composites, and other materials to retail, packaging, and construction markets. It operates through the following segments: UFP Retail Solutions (Retail), UFP Packaging (Packaging), UFP Construction (Construction), and All Other. The Retail segment consists of the following business units: ProWood, Deckorators, and UFP-Edge. The Packaging segment includes structural packaging, palletone, and protective packaging solutions. The Construction segment is involved in Factory-Built Housing, SiteBuilt Construction, Commercial Construction, and Concrete Forming. The All Other segment refers to the international segment and Ardellis. The company was founded in 1955 and is headquartered in Grand Rapids, MI. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Tutas David A. | Chief Comp Off, Gen Csl, Secty | May 14 '24 | Sale | 120.21 | 3,038 | 365,205 | 21,374 | May 14 05:01 PM | COLE MICHAEL R | Chief Financial Officer | May 13 '24 | Sale | 119.28 | 1,452 | 173,202 | 165,155 | May 14 02:42 PM | MERINO BRUCE A | Director | May 08 '24 | Sale | 117.88 | 16,472 | 1,941,685 | 7,107 | May 09 04:20 PM | MISSAD MATTHEW J | Chief Executive Officer | Mar 13 '24 | Sale | 114.02 | 24,982 | 2,848,448 | 338,346 | Mar 14 03:28 PM | MISSAD MATTHEW J | Chief Executive Officer | Mar 12 '24 | Sale | 114.05 | 5,018 | 572,303 | 363,328 | Mar 14 03:28 PM |
|
|
|
|
Market Cap | 3.18B | EPS (ttm) | 2.15 |
P/E | 35.00 | EPS this Y | 5.77% |
Forward P/E | 22.05 | EPS next Y | 12.56% |
PEG | 9.21 | EPS past 5Y | -9.80% |
P/S | 2.16 | EPS next 5Y | 3.80% |
P/B | 2.99 | EPS Q/Q | -8.16% |
Dividend | 2.24% | Sales Q/Q | 4.24% |
Insider Own | 16.34% | Inst Own | 75.26% |
Insider Trans | -0.01% | Inst Trans | -1.17% |
Short Float | 2.00% | Earnings | Apr 26/b |
Analyst Recom | 1.50 | Target Price | 79.00 |
Avg Volume | 225.57K | 52W Range | 52.90 - 78.70 |
|
|
|
Sensient Technologies Corp. engages in the manufacture of colors, flavors, and fragrances. It operates through the following segments: Flavors and Fragrances Group, Color Group, and Asia Pacific Group. The Flavors and Fragrances segment includes beverage flavors, bionutrients, savory flavors, sweet flavors, natural ingredients, and fragrance compounds and ingredients. The Color segment consists of natural and synthetic color solutions for the food and beverage, cosmetic, pharmaceutical, and industrial markets. The Asia Pacific segment markets product lines in the Pacific Rim under the Sensient name. The company was founded in 1882 and is headquartered in Milwaukee, WI. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
WHITELAW ESSIE | Director | May 10 '24 | Sale | 75.84 | 600 | 45,505 | 21,826 | May 14 05:01 PM | Morris Steven B | President, Flavors Group | Apr 30 '24 | Sale | 72.97 | 400 | 29,187 | 4,082 | May 01 05:59 PM | Manning Paul | Chairman, President & CEO | Feb 08 '24 | Option Exercise | 0.00 | 36,005 | 0 | 243,357 | Feb 09 06:01 PM | Manning John J | SVP, GC & Secretary | Feb 08 '24 | Option Exercise | 0.00 | 5,021 | 0 | 29,932 | Feb 09 05:59 PM | Jones Amy Schmidt | VP, HR and Senior Counsel | Feb 08 '24 | Option Exercise | 0.00 | 4,464 | 0 | 22,117 | Feb 09 05:57 PM |
|
|
|